日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer

DESTINY-Breast08:曲妥珠单抗德鲁替康联合其他抗癌疗法治疗HER2低表达转移性乳腺癌患者的Ib期研究

Jhaveri, Komal; Loi, Sherene; Hamilton, Erika; Schmid, Peter; Anders, Carey K; Testa, Laura; Wildiers, Hans; Tseng, Ling-Ming; Lu, Yen-Shen; Park, Yeon Hee; Im, Seock-Ah; Chen, Shin-Cheh; Young, Robyn R; Lloyd, Caron; Wrona, Magdalena; Zhang, Cuihong; Carroll, Danielle; André, Fabrice

QAL333's antitumor activity and predictive modeling: integrated transcriptomic-bioinformatic analysis reveals selective cytotoxicity and sensitivity determinants

QAL333的抗肿瘤活性和预测模型:整合转录组-生物信息学分析揭示选择性细胞毒性和敏感性决定因素

Kim, Hyon Hee; Im, Suji; Kim, Jiyun; Jo, Yebin; Hong, Eunbi; Jang, Soon Young; Sung, Jiha; Jacchetti, Emanuela; Raimondi, Manuela Teresa; Ryu, Eun-Ju; Kim, Yeong-Jun; Sim, Jaehyun; Park, Seyeon

Injury risk and epidemiology of pickleball players in South Korea: a cross-sectional study

韩国匹克球运动员的受伤风险和流行病学:一项横断面研究

Jeong, Boseok; Lee, Kang-Jun; Nam, Seung-Hee; Im, Sua; Lee, Rokbit S; Heo, Jinmoo; Kim, Kyung-Min

Optimizing radiotherapy in unresectable or metastatic intrahepatic cholangiocarcinoma: systematic review and meta-analysis of the literature

优化不可切除或转移性肝内胆管癌的放射治疗:文献系统评价和荟萃分析

Lee, Ik Jae; Bang, Ji-In; Choi, Seo Hee; Im, Jung Ho

Recombinant Cell-Permeable Puromycin N-Acetyltransferase Confers Puromycin Resistance by Direct Protein Transduction

重组细胞可渗透性嘌呤霉素N-乙酰转移酶通过直接蛋白转导赋予嘌呤霉素抗性

Choi, Jiwon; Cho, Kyung-Hee; Im, Jiwon; Seo, Yeeun; Sharma, Amitesh; Kartic; Devi, Shivani; Stalin, Nattan; Park, Seo Jin; Park, Tae-Sik

Encoding opposing valences through frequency-dependent transmitter switching in single peptidergic neurons

通过单个肽能神经元中频率依赖性递质转换来编码相反的价态

Kim, Dong-Il; Kang, Sukjae J; Jhang, Jinho; Jo, Yong S; Park, Seahyung; Ye, Mao; Pyeon, Gyeong Hee; Im, Geun-Ho; Kim, Seong-Gi; Han, Sung

Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial

SB3曲妥珠单抗生物类似药治疗ERBB2阳性早期乳腺癌的心脏安全性和疗效:一项随机临床试验的二次分析

Pivot, Xavier; Cortés, Javier; Lüftner, Diana; Lyman, Gary H; Curigliano, Giuseppe; Bondarenko, Igor M; Ahn, Jin-Hee; Im, Seock-Ah; Litwiniuk, Maria; Shparyk, Yaroslav V; Ho, Gwo Fuang; Kislov, Nikolay V; Wojtukiewicz, Marek; Sarosiek, Tomasz; Chae, Yee Soo; Ahn, Jin Seok; Jang, Hyerin; Kim, Sujung; Lee, Jiwon; Yoon, YeChan

Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

帕博利珠单抗联合化疗后序贯帕博利珠单抗治疗早期三阴性乳腺癌患者:一项随机临床试验的二次分析

Takahashi, Masato; Cortés, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kümmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Im, Seock-Ah; Ahn, Jin-Hee; Mukai, Hirofumi; Huang, Chiun-Sheng; Chen, Shin-Cheh; Kim, Min Hwan; Jia, Liyi; Li, Xin Tong; Tryfonidis, Konstantinos; Karantza, Vassiliki; Iwata, Hiroji; Schmid, Peter

Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

帕博西尼和来曲唑治疗后二线治疗策略的真实世界经验:转移性激素受体阳性、人表皮生长因子受体2阴性乳腺癌患者的总生存期

Kim, Ji-Yeon; Shin, Junghoon; Ahn, Jin Seok; Park, Yeon Hee; Im, Young-Hyuck

Incorporating axillary-lateral thoracic vessel juncture dosimetric variables improves model for predicting lymphedema in patients with breast cancer: A validation analysis

纳入腋窝-胸外侧血管交界处剂量学变量可改善乳腺癌患者淋巴水肿预测模型:一项验证性分析

Suk Chang, Jee; Ko, Heejoo; Hee Im, Sang; Sung Kim, Jin; Kyung Byun, Hwa; Bae Kim, Yong; Jung, Wonguen; Park, Goeun; Sun Lee, Hye; Sung, Wonmo; Olson, Robert; Hong, Chae-Seon; Kim, Kyubo